Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
73°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Savara Inc
(NQ:
SVRA
)
4.510
+0.250 (+5.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Savara Inc
< Previous
1
2
3
Next >
Savara to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From
Savara Inc.
Via
Business Wire
Savara Reports Second Quarter Financial Results and Provides Business Update
August 10, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
August 04, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
July 13, 2023
From
Savara Inc.
Via
Business Wire
Savara Added to Russell 3000® Index
June 26, 2023
From
Savara Inc.
Via
Business Wire
Savara Completes Enrollment of Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
June 26, 2023
From
Savara Inc.
Via
Business Wire
Savara to Present at the Jefferies Healthcare Conference
June 02, 2023
From
Savara Inc.
Via
Business Wire
Savara Reports First Quarter Financial Results and Provides Business Update
May 15, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
May 05, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
March 31, 2023
From
Savara Inc.
Via
Business Wire
Savara Reports Fourth Quarter / Year-End 2022 Financial Results and Provides Business Update
March 30, 2023
From
Savara Inc.
Via
Business Wire
Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 06, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
February 28, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Leadership Appointments
February 14, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
January 20, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
November 22, 2022
From
Savara Inc.
Via
Business Wire
Savara Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
From
Savara Inc.
Via
Business Wire
Savara to Participate in Three Upcoming Investor Conferences
November 09, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
September 14, 2022
From
Savara Inc.
Via
Business Wire
Savara Presented Data at the European Respiratory Society (ERS) International Congress 2022
September 06, 2022
From
Savara Inc.
Via
Business Wire
Savara to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 01, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces Resignation of Chief Medical Officer
August 26, 2022
From
Savara Inc.
Via
Business Wire
Savara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
August 25, 2022
From
Savara Inc.
Via
Business Wire
Savara Reports Second Quarter 2022 Financial Results and Provides Business Update
August 11, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces Acceptance of Three Abstracts at the European Respiratory Society (ERS) International Congress 2022
July 11, 2022
From
Savara Inc.
Via
Business Wire
Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic
June 16, 2022
From
Savara Inc.
Via
Business Wire
Savara to Present at Jefferies Healthcare Conference
June 01, 2022
From
Savara Inc.
Via
Business Wire
Savara to Present at H.C. Wainwright Global Investment Conference
May 17, 2022
From
Savara Inc.
Via
Business Wire
Savara Reports First Quarter 2022 Financial Results and Provides Business Update
May 11, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
April 26, 2022
From
Savara Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.